Tempest Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $37.1M | $73.2M | $51.8M |
| FY2022 | $28.0M | $46.1M | $31.2M |
| FY2023 | $24.8M | $51.6M | $39.2M |
| FY2024 | $22.4M | $41.5M | $30.3M |
| FY2025 | $10.3M | $16.9M | $7.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $37.1M | $73.2M | $51.8M |
| FY2022 | $28.0M | $46.1M | $31.2M |
| FY2023 | $24.8M | $51.6M | $39.2M |
| FY2024 | $22.4M | $41.5M | $30.3M |
| FY2025 | $10.3M | $16.9M | $7.7M |